Nga ra mắt thuốc điều trị COVID-19 đầu tiên được cấp phép

(Vietnam+) 07:55 12/06/2020

Ngày 11/6, Nga đã cho ra mắt loại thuốc điều trị bệnh viêm đường hô hấp cấp COVID-19 đầu tiên được cấp phép với tên gọi Avifavir, trong bối cảnh số ca mắc bệnh ở nước này đã vượt quá mốc 500.000 người.

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